Nga ra mắt thuốc điều trị COVID-19 đầu tiên được cấp phép

(Vietnam+) 07:55 12/06/2020

Ngày 11/6, Nga đã cho ra mắt loại thuốc điều trị bệnh viêm đường hô hấp cấp COVID-19 đầu tiên được cấp phép với tên gọi Avifavir, trong bối cảnh số ca mắc bệnh ở nước này đã vượt quá mốc 500.000 người.

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